Nga ra mắt thuốc điều trị COVID-19 đầu tiên được cấp phép

(Vietnam+) 07:55 12/06/2020

Ngày 11/6, Nga đã cho ra mắt loại thuốc điều trị bệnh viêm đường hô hấp cấp COVID-19 đầu tiên được cấp phép với tên gọi Avifavir, trong bối cảnh số ca mắc bệnh ở nước này đã vượt quá mốc 500.000 người.

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